Nga ra mắt thuốc điều trị COVID-19 đầu tiên được cấp phép

(Vietnam+) 07:55 12/06/2020

Ngày 11/6, Nga đã cho ra mắt loại thuốc điều trị bệnh viêm đường hô hấp cấp COVID-19 đầu tiên được cấp phép với tên gọi Avifavir, trong bối cảnh số ca mắc bệnh ở nước này đã vượt quá mốc 500.000 người.

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